Nga ra mắt thuốc điều trị COVID-19 đầu tiên được cấp phép

(Vietnam+) 07:55 12/06/2020

Ngày 11/6, Nga đã cho ra mắt loại thuốc điều trị bệnh viêm đường hô hấp cấp COVID-19 đầu tiên được cấp phép với tên gọi Avifavir, trong bối cảnh số ca mắc bệnh ở nước này đã vượt quá mốc 500.000 người.

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